Nga ra mắt thuốc điều trị COVID-19 đầu tiên được cấp phép

(Vietnam+) 07:55 12/06/2020

Ngày 11/6, Nga đã cho ra mắt loại thuốc điều trị bệnh viêm đường hô hấp cấp COVID-19 đầu tiên được cấp phép với tên gọi Avifavir, trong bối cảnh số ca mắc bệnh ở nước này đã vượt quá mốc 500.000 người.

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